Nga ra mắt thuốc điều trị COVID-19 đầu tiên được cấp phép

(Vietnam+) 07:55 12/06/2020

Ngày 11/6, Nga đã cho ra mắt loại thuốc điều trị bệnh viêm đường hô hấp cấp COVID-19 đầu tiên được cấp phép với tên gọi Avifavir, trong bối cảnh số ca mắc bệnh ở nước này đã vượt quá mốc 500.000 người.

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